Nga ra mắt thuốc điều trị COVID-19 đầu tiên được cấp phép

(Vietnam+) 07:55 12/06/2020

Ngày 11/6, Nga đã cho ra mắt loại thuốc điều trị bệnh viêm đường hô hấp cấp COVID-19 đầu tiên được cấp phép với tên gọi Avifavir, trong bối cảnh số ca mắc bệnh ở nước này đã vượt quá mốc 500.000 người.

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